Nga ra mắt thuốc điều trị COVID-19 đầu tiên được cấp phép

(Vietnam+) 07:55 12/06/2020

Ngày 11/6, Nga đã cho ra mắt loại thuốc điều trị bệnh viêm đường hô hấp cấp COVID-19 đầu tiên được cấp phép với tên gọi Avifavir, trong bối cảnh số ca mắc bệnh ở nước này đã vượt quá mốc 500.000 người.

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